Nga ra mắt thuốc điều trị COVID-19 đầu tiên được cấp phép

(Vietnam+) 07:55 12/06/2020

Ngày 11/6, Nga đã cho ra mắt loại thuốc điều trị bệnh viêm đường hô hấp cấp COVID-19 đầu tiên được cấp phép với tên gọi Avifavir, trong bối cảnh số ca mắc bệnh ở nước này đã vượt quá mốc 500.000 người.

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